Nga ra mắt thuốc điều trị COVID-19 đầu tiên được cấp phép

(Vietnam+) 07:55 12/06/2020

Ngày 11/6, Nga đã cho ra mắt loại thuốc điều trị bệnh viêm đường hô hấp cấp COVID-19 đầu tiên được cấp phép với tên gọi Avifavir, trong bối cảnh số ca mắc bệnh ở nước này đã vượt quá mốc 500.000 người.

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